Nga ra mắt thuốc điều trị COVID-19 đầu tiên được cấp phép

(Vietnam+) 07:55 12/06/2020

Ngày 11/6, Nga đã cho ra mắt loại thuốc điều trị bệnh viêm đường hô hấp cấp COVID-19 đầu tiên được cấp phép với tên gọi Avifavir, trong bối cảnh số ca mắc bệnh ở nước này đã vượt quá mốc 500.000 người.

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